Nga ra mắt thuốc điều trị COVID-19 đầu tiên được cấp phép

(Vietnam+) 07:55 12/06/2020

Ngày 11/6, Nga đã cho ra mắt loại thuốc điều trị bệnh viêm đường hô hấp cấp COVID-19 đầu tiên được cấp phép với tên gọi Avifavir, trong bối cảnh số ca mắc bệnh ở nước này đã vượt quá mốc 500.000 người.

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